Nga ra mắt thuốc điều trị COVID-19 đầu tiên được cấp phép

(Vietnam+) 07:55 12/06/2020

Ngày 11/6, Nga đã cho ra mắt loại thuốc điều trị bệnh viêm đường hô hấp cấp COVID-19 đầu tiên được cấp phép với tên gọi Avifavir, trong bối cảnh số ca mắc bệnh ở nước này đã vượt quá mốc 500.000 người.

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